Nga ra mắt thuốc điều trị COVID-19 đầu tiên được cấp phép

(Vietnam+) 07:55 12/06/2020

Ngày 11/6, Nga đã cho ra mắt loại thuốc điều trị bệnh viêm đường hô hấp cấp COVID-19 đầu tiên được cấp phép với tên gọi Avifavir, trong bối cảnh số ca mắc bệnh ở nước này đã vượt quá mốc 500.000 người.

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